Nga ra mắt thuốc điều trị COVID-19 đầu tiên được cấp phép

(Vietnam+) 07:55 12/06/2020

Ngày 11/6, Nga đã cho ra mắt loại thuốc điều trị bệnh viêm đường hô hấp cấp COVID-19 đầu tiên được cấp phép với tên gọi Avifavir, trong bối cảnh số ca mắc bệnh ở nước này đã vượt quá mốc 500.000 người.

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